Nga ra mắt thuốc điều trị COVID-19 đầu tiên được cấp phép

(Vietnam+) 07:55 12/06/2020

Ngày 11/6, Nga đã cho ra mắt loại thuốc điều trị bệnh viêm đường hô hấp cấp COVID-19 đầu tiên được cấp phép với tên gọi Avifavir, trong bối cảnh số ca mắc bệnh ở nước này đã vượt quá mốc 500.000 người.

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